Nga ra mắt thuốc điều trị COVID-19 đầu tiên được cấp phép

(Vietnam+) 07:55 12/06/2020

Ngày 11/6, Nga đã cho ra mắt loại thuốc điều trị bệnh viêm đường hô hấp cấp COVID-19 đầu tiên được cấp phép với tên gọi Avifavir, trong bối cảnh số ca mắc bệnh ở nước này đã vượt quá mốc 500.000 người.

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